Nga ra mắt thuốc điều trị COVID-19 đầu tiên được cấp phép

(Vietnam+) 07:55 12/06/2020

Ngày 11/6, Nga đã cho ra mắt loại thuốc điều trị bệnh viêm đường hô hấp cấp COVID-19 đầu tiên được cấp phép với tên gọi Avifavir, trong bối cảnh số ca mắc bệnh ở nước này đã vượt quá mốc 500.000 người.

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